Margaret Olinger
Chief Commercial Officer, Amylyx Pharmaceuticals.
Companies
- Amylyx PharmaceuticalsChief Commercial Officer Jan 6, 2022 to Dec 29, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Amylyx Pharmaceuticals AMLX276,108 shares2$7.5M at $27.07Dec 27, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 27, 2023Exercised options 25,000 shares at $0.37 of Amylyx Pharmaceuticals2
- Jul 12, 2023Exercised options 20,000 shares at $0.37 of Amylyx Pharmaceuticals3
- May 22, 2023Gift 1,580 shares of Amylyx Pharmaceuticals4
- Mar 16, 2023Granted 18,333 shares of Amylyx Pharmaceuticals5
- Jan 6, 2023Sold 743 shares at $36.79 of Amylyx Pharmaceuticals6
- Jan 6, 2023Sold 1,660 shares at $36.08 of Amylyx Pharmaceuticals6
- Jan 6, 2022Bought 6,842 shares at $19.00 of Amylyx Pharmaceuticals7
- Jan 6, 2022Granted 28,333 shares of Amylyx Pharmaceuticals7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jul 14, 2023
- 4SEC EDGARForm 4 filed May 24, 2023
- 5SEC EDGARForm 4 filed Mar 20, 2023
- 6SEC EDGARForm 4 filed Jan 10, 2023
- 7SEC EDGARForm 4 filed Jan 10, 2022